None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Adults aged 19 to 75 years old 2) Those in need of treatment due to unruptured Wide-neck Saccular Aneurysm 3) A person who voluntarily decides to participate in this clinical trial and signs a consent form
Exclusion criteria
Exclusion criteria: 1) If an aneurysm is ruptured 2) If you currently have two tumors or are receiving radiation therapy for carcinoma or sarcoma in the head and neck 3) If you have a heart disease that is likely to be related to heart embolism symptoms such as atrial fibrillation (AFIB) 4) If the patient is at high risk of embolic stroke according to the investigator opinion 5) Patients contraindicated with anticoagulants, antiplatelet drugs or thrombolytic drugs 6) Arteriovenous malformation in aneurysms 7) If it is judged that participation in this clinical trial is inappropriate according to the judgment of other researchers [Items to be confirmed on the day of coil embolization] 8) When there is difficulty in passing or placing the stent due to an anatomical problem 9) In case the aneurysm is not suitable for endovascular treatment during the actual procedure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cerebral aneurysm occlusion success rate at 6 months after the procedure (%) | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of complications after stent procedure (%);Recure rate (%);Stent procedure success rate (%) | — |
Countries
Korea, Republic of
Contacts
Yonsei University Health System, Severance Hospital